Caffeine Ingestion to Counter the Exercise-mediated Fall in Glycaemia in Type 1 Diabetes (DE-CAF)

NCT04671043 NA COMPLETED

This project will aim to investigate the clinical efficacy and metabolic effects of a pre-exercise dose of caffeine with a low (10g) dose of carbohydrate (CAF+lowCHO) without modification of insulin degludec on exercise metabolism in people with T1D.

Details

Lead sponsor	Insel Gruppe AG, University Hospital Bern
Phase	NA
Status	COMPLETED
Enrolment	21
Start date	Fri Feb 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Feb 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Caffeine and Carbohydrate
• Carbohydrate Only
• Placebo

Interventions

• Caffeine and glucose
• Glucose alone
• Placebo

Countries

Switzerland